You just read:

S*BIO Initiates Phase 2 Clinical Trial of its Novel JAK2 Inhibitor SB1518 in North America for Advanced Lymphoid Malignancies

News provided by

S*BIO Pte Ltd

Apr 14, 2011, 09:00 ET